Transitioning can have a significant impact on fertility for FTM individuals. Testosterone therapy, which is one of the most common forms of medical transition for FTM individuals, can make it difficult or impossible to get pregnant. Additionally, many FTM individuals have their uterus and ovaries removed as part of their transition, which would also make it impossible to get pregnant.

However, it is important to note that there are some FTM individuals who have chosen to become pregnant and give birth after transitioning. These individuals may have stopped taking testosterone therapy or may have had their uterus and ovaries removed after they had children.

If you are an FTM individual who is considering pregnancy, it is important to talk to your doctor about the risks and benefits of pregnancy after transitioning. Your doctor can help you to determine if pregnancy is right for you and can provide you with the information and support you need to make an informed decision.

Here are some additional resources that you may find helpful:

  • The National Center for Transgender Equality:
  • The Human Rights Campaign:
  • The Trevor Project:
  • Trans Lifeline:

The impact of transitioning on fertility for FTM (female-to-male) individuals can vary. Here are some key considerations:

  1. Testosterone Hormone Therapy: Testosterone hormone therapy, which is a common component of FTM transition, typically leads to a temporary cessation of menstrual cycles and ovulation. This means that while on testosterone, FTM individuals are unlikely to conceive naturally.
  2. Irreversible Effects: Prolonged use of testosterone can have irreversible effects on fertility. Testosterone therapy can suppress ovarian function, leading to atrophy of the ovaries and decreased egg production. It’s important to understand that fertility may not fully recover after discontinuing testosterone.
  3. Temporary Cessation of Hormone Therapy: Some FTM individuals may choose to temporarily pause testosterone hormone therapy in order to attempt conception. This pause allows for the return of menstrual cycles and potential ovulation, increasing the possibility of natural conception. However, it’s essential to consult with healthcare providers experienced in transgender healthcare and fertility to understand the timing and implications of pausing hormone therapy.
  4. Assisted Reproductive Technologies (ART): FTM individuals who wish to have biological children after transitioning may explore assisted reproductive technologies such as fertility preservation, intrauterine insemination (IUI), or in vitro fertilization (IVF). Fertility preservation options, such as freezing eggs or embryos prior to starting testosterone therapy, can be considered as a proactive measure.
  5. Ovarian Tissue Cryopreservation: In some cases, FTM individuals who have not undergone extensive hormone therapy may choose to undergo ovarian tissue cryopreservation. This procedure involves removing and freezing ovarian tissue for potential future transplantation or extraction of eggs.

It’s crucial for FTM individuals who are considering transitioning and have concerns about fertility to consult with healthcare providers, including reproductive endocrinologists or fertility specialists, who have experience in working with transgender individuals. These professionals can provide personalized guidance, discuss fertility preservation options, and help navigate the potential impact of transitioning on fertility based on individual circumstances.

It’s important to note that fertility options and success rates can vary based on individual factors, including age, overall health, and medical history. Seeking professional guidance and discussing fertility intentions before starting hormone therapy can help individuals make informed decisions about their reproductive future.